Yijia Wang Selected Research

kang-lai-te

4/2018	Author Correction: Kanglaite sensitizes colorectal cancer cells to Taxol via NF-κΒ inhibition and connexin 43 upregulation.
1/2018	Kanglaite inhibits EMT caused by TNF-α via NF-κΒ inhibition in colorectal cancer cells.
1/2017	Kanglaite sensitizes colorectal cancer cells to Taxol via NF-κΒ inhibition and connexin 43 upregulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yijia Wang Research Topics

Disease

21	Neoplasms (Cancer) 04/2024 - 09/2000
14	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 01/2017
4	Myocardial Infarction 07/2023 - 01/2017
4	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2018
3	Inflammation (Inflammations) 01/2024 - 03/2016
3	Lymphoma (Lymphomas) 06/2002 - 09/2000
2	Familial Primary Pulmonary Hypertension 05/2024 - 01/2024
2	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2022
2	Cleft Palate (Palate, Cleft) 08/2023 - 01/2022
2	Diabetic Foot 05/2023 - 03/2021
2	Rheumatoid Arthritis 01/2023 - 01/2022
2	Wounds and Injuries (Trauma) 03/2021 - 01/2020
1	Insulin Resistance 05/2024
1	Iron Overload 02/2024
1	Pulmonary Hypertension 01/2024
1	Pheochromocytoma 11/2023
1	Hypoxia (Hypoxemia) 03/2023
1	Pain (Aches) 01/2023
1	Bone Resorption 01/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Hyperalgesia 01/2023
1	COVID-19 01/2023
1	Obesity 01/2023
1	Phototoxic Dermatitis (Phototoxicity) 09/2022
1	Weight Loss (Weight Reduction) 07/2022
1	Iron Deficiencies 03/2022
1	Congenital Abnormalities (Deformity) 01/2022
1	Klatskin Tumor 01/2022
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022
1	Crohn Disease (Crohn's Disease) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Relative Energy Deficiency in Sport 12/2021
1	Ulcer 03/2021

Drug/Important Bio-Agent (IBA)

6	Connexin 43 (Connexin43)IBA 09/2022 - 05/2016
5	IronIBA 02/2024 - 01/2022
4	Cetuximab (Erbitux)FDA Link 01/2023 - 01/2020
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2017
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2023 - 01/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 03/2016
3	kang-lai-teIBA 04/2018 - 01/2017
2	AntioxidantsIBA 02/2024 - 01/2022
2	EnzymesIBA 12/2023 - 09/2019
2	Proteins (Proteins, Gene)FDA Link 03/2023 - 01/2023
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2022
2	CytokinesIBA 01/2023 - 01/2018
2	CollagenIBA 01/2023 - 12/2021
2	platycodin DIBA 01/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2021
2	Monoclonal AntibodiesIBA 01/2022 - 07/2020
2	EpitopesIBA 06/2002 - 02/2002
2	AntibodiesIBA 06/2002 - 02/2002
2	DNA VaccinesIBA 02/2002 - 09/2000
1	Insulin (Novolin)FDA Link 05/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2024
1	liensinineIBA 04/2024
1	Calcitriol (Calcijex)FDA LinkGeneric 02/2024
1	Trastuzumab (Herceptin)FDA Link 01/2024
1	Tumor Biomarkers (Tumor Markers)IBA 01/2024
1	Biosimilar PharmaceuticalsIBA 01/2024
1	pertuzumabIBA 01/2024
1	Docetaxel (Taxotere)FDA Link 01/2024
1	CeruleninIBA 12/2023
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 12/2023
1	Epinephrine (Adrenaline)FDA LinkGeneric 11/2023
1	plerixafor FDA Link 08/2023
1	Monomeric GTP-Binding ProteinsIBA 08/2023
1	rhoA GTP-Binding ProteinIBA 08/2023
1	HydrogelsIBA 07/2023
1	Oxygen (Dioxygen)IBA 07/2023
1	CalciumIBA 05/2023
1	Serum AlbuminIBA 05/2023
1	TriterpenesIBA 01/2023
1	HepcidinsIBA 01/2023
1	CateninsIBA 01/2023
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2023
1	Mitogen-Activated Protein KinasesIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	regorafenibIBA 01/2023
1	Vincristine (Oncovin)FDA LinkGeneric 01/2023
1	SaponinsIBA 01/2023
1	Streptozocin (Streptozotocin)FDA Link 01/2023
1	PlasticsIBA 07/2022
1	ethyleneIBA 03/2022
1	ChlorophyllIBA 03/2022
1	Indoleacetic Acids (Auxin)IBA 03/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	6-propylchromone-2-carboxylic acid (PCCA)IBA 01/2022
1	angiogeninIBA 12/2021

Therapy/Procedure

12	Therapeutics 04/2024 - 01/2017
4	Drug Therapy (Chemotherapy) 01/2023 - 08/2017
3	Microbubbles 12/2021 - 01/2017
1	Neoadjuvant Therapy 01/2024
1	Length of Stay 01/2023
1	Photochemotherapy (Photodynamic Therapy) 09/2022
1	Treatment Delay 01/2022
1	Precision Medicine 10/2021